Products for cold storage of embryos approved in USA

Vitrolife is now the first company to have received approval from the American Food and Drug Administration for products within the fertility area used for the rapid freezing and thawing of cleavage embryos (embryos on day 3 after fertilization), so-called vitrification.

The two vitrification products that Vitrolife has obtained approval for are RapidVit™ Cleave och RapidWarm™ Cleave. “These are two very important products for us, as the majority of the clinics that freeze embryos do so at the very stage that the products are intended for, day 3 after fertilization” says Nils Sellbom, Director of Marketing and Sales at Vitrolife.

The two products, and two further vitrification products, RapidVit™ Blast och RapidWarm™ Blast (for rapid freezing and thawing of blastocysts, embryos on days 5-7 after fertilization), have already been approved in Europe and Canada.

Products for vitrification involve considerable technological progress since survival increases after cold storage. The chance of achieving a good cumulative pregnancy frequency thereby increases for the woman, without her having to undergo new hormone treatment and the removal of more oocytes.




December 5, 2008
Gothenburg, Sweden

Magnus Nilsson
CEO






Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.